Long-term (15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY

Fabrizio D'Ascenzo1, Edoardo Elia1, Giorgio Marengo1

  • 1Department of Medical Science, Città Della Salute e della Scienza, Division of Cardiology, Turin, Italy.

Insights

Long-term survival after Percutaneous Coronary Intervention (PCI) for Unprotected Left Main Coronary Artery (ULMCA) shows 47% mortality over 15 years. Key risk factors for death include older age, lower LVEF, and multiple vessels treated.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Percutaneous Coronary Intervention (PCI) for Unprotected Left Main Coronary Artery (ULMCA) is a complex procedure.
  • Long-term survival data and predictors of mortality after ULMCA PCI are crucial for patient management and risk stratification.

Purpose of the Study:

  • To evaluate long-term survival and identify determinants of mortality after PCI on ULMCA.
  • To assess the impact of repeated PCI on ULMCA on long-term outcomes.

Main Methods:

  • Retrospective analysis of 470 consecutive patients undergoing PCI on ULMCA between 2002 and 2005 across 9 European centers.
  • Primary endpoints were all-cause and cardiovascular (CV) death; secondary endpoints were predictors of mortality identified via multivariate analysis.
  • Follow-up extended to 15 years, with assessment of repeated PCI procedures.

Main Results:

  • After a median of 15 years, 47% of patients died from all causes, and 17.2% died from CV causes.
  • Multivariable analysis identified older age, left ventricular ejection fraction (LVEF) < 35%, and the number of vessels treated during index PCI as predictors of all-cause mortality.
  • Only LVEF < 35% was a significant predictor of CV death. Repeated PCI on ULMCA did not significantly impact survival.

Conclusions:

  • PCI on ULMCA in a large, unselected population is associated with significant long-term mortality.
  • Older age, reduced LVEF, and treatment of multiple vessels during the initial PCI are associated with increased all-cause mortality.
  • Repeated PCI procedures on ULMCA do not appear to influence long-term survival outcomes.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
286
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74